Literature DB >> 16444580

Glioma: what is the role of c-Myc, hsp90 and telomerase?

A Shervington1, N Cruickshanks, H Wright, R Atkinson-Dell, R Lea, G Roberts, L Shervington.   

Abstract

The continuous advancements in cancer research have contributed to the overwhelming evidence of the presence of telomerase in primary and secondary tumours together with hsp90 and c-Myc. This review will discuss the important role of telomerase together with hsp90 and c-Myc within the initiation and progression of gliomas. Also it will review the differential expression of these genes in the different grades of gliomas and the possibility of new treatments targeting these specific genes.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16444580     DOI： 10.1007/s11010-006-2495-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN： 0300-8177            Impact factor:   3.396


  60 in total

Review 1.  Telomerase inhibitors.

Authors:  L K White; W E Wright; J W Shay
Journal:  Trends Biotechnol       Date:  2001-03       Impact factor: 19.536

Review 2.  From the cradle to the grave: molecular chaperones that may choose between folding and degradation.

Authors:  J Höhfeld; D M Cyr; C Patterson
Journal:  EMBO Rep       Date:  2001-10       Impact factor: 8.807

Review 3.  Heat, heat shock, heat shock proteins and death: a central link in innate and adaptive immune responses.

Authors:  K M Anderson; P K Srivastava
Journal:  Immunol Lett       Date:  2000-09-15       Impact factor: 3.685

Review 4.  Telomerase inhibition and telomere erosion: a two-pronged strategy in cancer therapy.

Authors:  Fred O Odago; Stanton L Gerson
Journal:  Trends Pharmacol Sci       Date:  2003-07       Impact factor: 14.819

Review 5.  Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement.

Authors:  William B Pratt; Mario D Galigniana; Jennifer M Harrell; Donald B DeFranco
Journal:  Cell Signal       Date:  2004-08       Impact factor: 4.315

6.  Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII.

Authors:  Sylvie J Lavictoire; Doris A E Parolin; Alex C Klimowicz; John F Kelly; Ian A J Lorimer
Journal:  J Biol Chem       Date:  2002-12-05       Impact factor: 5.157

Review 7.  Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts.

Authors:  Igor B Roninson
Journal:  Cancer Lett       Date:  2002-05-08       Impact factor: 8.679

8.  The correlation of TERT expression with c-myc expression in cervical cancer.

Authors:  Y Sagawa; H Nishi; K Isaka; A Fujito; M Takayama
Journal:  Cancer Lett       Date:  2001-07-10       Impact factor: 8.679

9.  Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation.

Authors:  Judith Haendeler; Jörg Hoffmann; Sandy Rahman; Andreas M Zeiher; Stefanie Dimmeler
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

10.  Geldanamycin induces mitotic catastrophe and subsequent apoptosis in human glioma cells.

Authors:  Motohiro Nomura; Naoko Nomura; Elizabeth W Newcomb; Yevgeniy Lukyanov; Cristina Tamasdan; David Zagzag
Journal:  J Cell Physiol       Date:  2004-12       Impact factor: 6.384
View more
  17 in total

1.  Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.

Authors:  Qing Ouyang; Gang Chen; Ji Zhou; Lei Li; Zhen Dong; Rui Yang; Lunshan Xu; Hongjuan Cui; Minhui Xu; Liang Yi
Journal:  Neuro Oncol       Date:  2015-07-14       Impact factor: 12.300

2.  Activation of Multiple Molecular Mechanisms for Increasing Apoptosis in Human Glioblastoma T98G Xenograft.

Authors:  Surajit Karmakar; Subhasree Roy Choudhury; Naren L Banik; Swapan K Ray
Journal:  J Cancer Sci Ther       Date:  2010-06-26

Review 3.  HSP90 manages the ends.

Authors:  Diane C DeZwaan; Brian C Freeman
Journal:  Trends Biochem Sci       Date:  2010-03-16       Impact factor: 13.807

Review 4.  The TERT rs2736100 polymorphism and cancer risk: a meta-analysis based on 25 case-control studies.

Authors:  Peng Zou; Aihua Gu; Guixiang Ji; Lin Zhao; Peng Zhao; Ailin Lu
Journal:  BMC Cancer       Date:  2012-01-05       Impact factor: 4.430

5.  Myc down-regulation affects cyclin D1/cdk4 activity and induces apoptosis via Smac/Diablo pathway in an astrocytoma cell line.

Authors:  D Amendola; M De Salvo; R Marchese; C Verga Falzacappa; A Stigliano; E Carico; E Brunetti; M Moscarini; B Bucci
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

6.  klumpfuss distinguishes stem cells from progenitor cells during asymmetric neuroblast division.

Authors:  Qi Xiao; Hideyuki Komori; Cheng-Yu Lee
Journal:  Development       Date:  2012-06-28       Impact factor: 6.868

7.  Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells.

Authors:  Surajit Karmakar; Naren L Banik; Swapan K Ray
Journal:  Neurochem Res       Date:  2007-06-12       Impact factor: 3.996

8.  Large scale hippocampal cellular distress may explain the behavioral consequences of repetitive traumatic experiences--a proteomic approach.

Authors:  Joachim D K Uys; Suzél M Hattingh; Dan J Stein; Willie M U Daniels
Journal:  Neurochem Res       Date:  2008-02-29       Impact factor: 3.996

Review 9.  Protein tyrosine phosphatases in glioma biology.

Authors:  Anna C Navis; Monique van den Eijnden; Jan T G Schepens; Rob Hooft van Huijsduijnen; Pieter Wesseling; Wiljan J A J Hendriks
Journal:  Acta Neuropathol       Date:  2009-11-21       Impact factor: 17.088

10.  Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

Authors:  Margaret Wrensch; Robert B Jenkins; Jeffrey S Chang; Ru-Fang Yeh; Yuanyuan Xiao; Paul A Decker; Karla V Ballman; Mitchel Berger; Jan C Buckner; Susan Chang; Caterina Giannini; Chandralekha Halder; Thomas M Kollmeyer; Matthew L Kosel; Daniel H LaChance; Lucie McCoy; Brian P O'Neill; Joe Patoka; Alexander R Pico; Michael Prados; Charles Quesenberry; Terri Rice; Amanda L Rynearson; Ivan Smirnov; Tarik Tihan; Joe Wiemels; Ping Yang; John K Wiencke
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.